DORA PEREZ: Open Payments
NPI 1467852251 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,630 in 137 payments from 25 companies in 2025. Trend: 2023 $169 · 2024 $4,325 · 2025 $2,630
Food & beverage: $2,585Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $340 |
| UCB, Inc. | 19 | $317 |
| Boston Scientific Corporation | 3 | $255 |
| Teva Pharmaceuticals USA, Inc. | 13 | $254 |
| Amneal Pharmaceuticals LLC | 22 | $164 |
| Neurelis, Inc. | 10 | $144 |
| InSightec,Inc | 2 | $108 |
| ARGENX US, INC. | 6 | $98 |
| Neurocrine BioSciences, Inc. | 5 | $93 |
| SERVIER PHARMACEUTICALS LLC | 5 | $91 |
Products named: General - DBS, AUSTEDO XR, VYALEV, CREXONT, VALTOCO, Briviact, Exablate, INGREZZA.
Industry payments across NY — which companies pay providers there.
